| Literature DB >> 33907522 |
Shigao Huang1, Jie Yang2,3, Simon Fong2, Qi Zhao1.
Abstract
Artificial intelligence (AI) is being used to aid in various aspects of the COVID-19 crisis, including epidemiology, molecular research and drug development, medical diagnosis and treatment, and socioeconomics. The association of AI and COVID-19 can accelerate to rapidly diagnose positive patients. To learn the dynamics of a pandemic with relevance to AI, we search the literature using the different academic databases (PubMed, PubMed Central, Scopus, Google Scholar) and preprint servers (bioRxiv, medRxiv, arXiv). In the present review, we address the clinical applications of machine learning and deep learning, including clinical characteristics, electronic medical records, medical images (CT, X-ray, ultrasound images, etc.) in the COVID-19 diagnosis. The current challenges and future perspectives provided in this review can be used to direct an ideal deployment of AI technology in a pandemic. © The author(s).Entities:
Keywords: Artificial intelligence; COVID-19; deep learning; diagnosis; machine learning
Mesh:
Year: 2021 PMID: 33907522 PMCID: PMC8071762 DOI: 10.7150/ijbs.58855
Source DB: PubMed Journal: Int J Biol Sci ISSN: 1449-2288 Impact factor: 6.580
Application of machine learning-based COVID-19 diagnosis
| Authors | Countries | Data Sources | No. of Patients | Techniques | Performances |
|---|---|---|---|---|---|
| An et al. | Korea | KNHIS | 10237 | LASSO, LSVM, SVM with radial basis function kernel, RF, KNN | Sensitivities (90.7% [95% confidence interval: 83.3, 97.3] and 92.0% [85.9, 98.1], respectively) Specificities (91.4% [90.3, 92.5] and 91.8%, [90.7, 92.9], respectively) AUC (0.963 [0.946, 0.979] and 0.962 [0.945, 0.979], respectively) |
| Zoabi et al. | Israel | Israeli Ministry of Health | 8393 | Gradient boosting with decision tree | 0.90 auROC 95% CI: 0.892-0.905 |
| Batista et al. | Brazil | Brazilian Ministry of Health | 235 | Neural networks,RF,LR,SVM,Gradient boosting trees | AUC: 0.85; Sensitivity: 0.68; Specificity: 0.85; Brier Score: 0.16 |
| Prefeitura et al. | Brazil | Public Health Department | 3916 | Random forest | Accuracy:0.66 (UI 95%0.62-0.69)Sensitivity:0.65 (UI 95%0.57-0.75);Specificity:0.66 (UI 95%0.60-0.70) |
| Mei et al. | China | 18 medical centers | 419 | CNN, SVM, RF, MLP | AUC 0.92 |
| Chen et al. | China | Union Hospital, Wuhan, China | 214 | RF | Accuracy>95% |
| Li et al. | USA | Public data | 413 | XGBoost | Sensitivity 92.5%;Specificity 97.9% |
| Avila et al. | Brazil | Hospital Israelita Albert Einstein | 510 | Naïve Bayes Classifier | Sensitivity and Specificity 76.7% |
*Public data:https://github.com/yoshihiko1218/COVID19ML, KNHIS: Korean National Health Insurance Service, SVM: Support Vector Machines, LSVM: Linear support vector machine,NB: Naïve Bayes, RF: Random Forest, LR: Logistic Regression, KNN: K-nearest neighbors, ET: Extremely Randomized Trees, DT: Decision Tree, CNN: Convolutional Neural Networks, MLP: Multi-layer perceptron, LASSO: Least absolute shrinkage and selection operator, AUROC: Area under the receiver operating characteristic curve, AUC: Area under the curve
Application of deep learning-based COVID-19 diagnosis
| Authors | Data Sources | No. of Images | Type of Images | No. of Classes | Techniques | Type of model | Performances |
|---|---|---|---|---|---|---|---|
| Ardakani et al. | Real-time data fromuniversity hospital | 1020 (COVID19=510,non-COVID19=510) | CT | 2 (COVID-19,non-COVID19) | AlexNet, VGG16, VGG-19,SqueezeNet, GoogleNet, MobileNet-V2, ResNet-18, ResNet-50, ResNet-101, Xception | Pre-trained model | Accuracy=99.51, Sensitivity=100, Specificity=99.02, Precision=99.27, AUC=99.4, NPV=100 |
| Wu et al. | China Medical University, Beijing Youan Hospital | 495 (COVID19=368, otherpneumonia=127) | CT | 2 (COVID-19, other pneumonia) | ResNet50 | Pre-trained model | Accuracy=76, Sensitivity=81.1, Specificity=61.5, AUC=81.9 |
| Cifci | kaggle.com (benchmarkweb of dataset science) | 5800 | CT | 2 (COVID-19, other pneumonia) | AlexNet, Inception-V4 | Pre-trained model | Accuracy=94.74, Sensitivity=87.37, Specificity=87.45 |
| Apostolopoulosand Bessiana | COVID-19 X-ray imagedatabase | 1442 (COVID19=224,pneumonia=714,normal=504) | X-RAY | 3 (COVID-19, pneumonia, normal) | VGG19, MobileNetv2, Inception, Xception, InceptionResNetv2 | Pre-trained model | Accuracy=96.78, Sensitivity=98.66, Specificity=96.46 |
| Loey et al. | COVID-19 X-ray imagedatabase | 307(COVID=69, normal=79,pneumonia_bac=79,pneumonia_vir=79) | X-RAY | 4 (COVID, normal, pneumonia_ba, pneumonia_vir) | GAN, Alexnet, Googlenet, Resnet18 | Pre-trained model | Accuracy=85.2, Precision= 80.6, |
| Hasan et al. | COVID-19 Dataset*, SPIEAAPM-NCI Lung NoduleClassification Challenge Dataset | 321 (COVID19=118,pneumonia=96,healthy=107) | CT | 3 (COVID19, pneumonia, healthy) | QDE-DF | Customized Model | Accuracy=99.68 |
| Amyar et al. | COVID-CT | 1044 (COVID19=449, nonCOVID-19=595) | CT | 2 (COVID19, nonCOVID-19) | EncoderDecoder withmulti-layerperceptron | Customized Model | Accuracy=86, Sensitivity=94, Specificity=79, AUC=93 |
| Ozturk etal. | COVID-19 X-ray image database | 1127 (COVID=127,no-finding=500,pneumonia=500) | X-RAY | 3 (COVID, nofinding,pneumonia) | DarkNet | Customized Model | Accuracy=98.08, Sensitivity=95.13, Specificity=95.3, Precision=98.03, F1-Score=96.51 |
| Rahimzadeh and Attar | COVID-19 X-ray image database | 15085 (COVID19=180, pneumonia=6054, normal= 8851) | X-RAY | 3 (COVID-19, pneumonia, normal) | ConcatenatedCNN | Customized Model | Accuracy=99.50, Sensitivity=80.53, Specificity=99.56 |
*Kaggle dataset: https://www.kaggle.com/andrewmvd/convid19-x-rays,
Dataset: https://drive.google.com/uc?id=1coM7x3378fOu2l6Pg2wldaOI7Dntu1a,
Covid-19 Dataset: https://radiopaedia.org,
Archive, C.I. SPIE-AAPM-NCI Lung Nodule Classification Challenge Dataset: https://www.cancerimagingarchive.net,
COVID-19 CT segmentation dataset: http://medicalsegmentation.com/covid19/ .Note: CT: computerized tomography; CNN: Convolutional Neural Network
Challenges and perspectives of machine learning-based COVID-19 diagnosis
| Challenges | Perspectives |
|---|---|
| Improve the accuracy of the AI diagnosis | Combine chest imaging with clinical symptoms, exposure history, and laboratory tests in the diagnosis of COVID-19 |
| Reduce the false negative diagnosis rate | Provides spare capacity for CT and X-ray imaging scans with the advantages of rapid COVID-19 diagnosis. |